BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/2/2023 9:29:03 AM | Browse: 200 | Download: 574
 |
Received |
|
2023-03-23 13:10 |
|
Peer-Review Started |
|
2023-03-23 13:14 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-06-17 11:21 |
|
Revised |
|
2023-06-28 15:05 |
|
Second Decision |
|
2023-07-14 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-07-17 01:27 |
|
Articles in Press |
|
2023-07-17 01:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-07-21 03:08 |
|
Publish the Manuscript Online |
|
2023-08-02 09:29 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Liang-Fang Wang, Ping-Run Chen, Si-Ke He, Shi-Hao Duan and Yan Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yan Zhang, MD, PhD, Chief Physician, Doctor, Doctor, Professor, Department of Gastroenterology and Hepatology, West China Hospita, Sichuan University, No. 37 Guoxue Street, Chengdu 610041, Sichuan Province, China. hxzyan@163.com |
| Key Words |
Predictor; Management; Tumor necrosis factor antagonist; Primary nonresponse; Secondary nonresponse; Inflammatory bowel disease |
| Core Tip |
Tumor necrosis factor-α (TNF-α) antagonists play an essential role in the management of inflammatory bowel disease (IBD). However, a significant number of patients experience primary or secondary nonresponse to these drugs. Here, we summarize relevant predictors of anti-TNF nonresponse in IBD and discuss the next steps for treating patients with primary or secondary nonresponse to anti-TNF agents. |
| Publish Date |
2023-08-02 09:29 |
| Citation |
Wang LF, Chen PR, He SK, Duan SH, Zhang Y. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review. World J Gastroenterol 2023; 29(29): 4481-4498 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i29/4481.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i29.4481 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
